Proposed closure of the NIH Fogarty Center would negatively impact U.S. research

It’s not news by now that the proposed 2018 budget calls for a $2 billion cut to the NIH. But a specific line item in the proposed budget that still comes as a shock to the global public health community is the administration’s call to shut down the NIH Fogarty International Center (FIC). The FIC is lauded by leading experts as a juggernaut in the fight against everything from AIDS to Ebola, and from Zika to influenza. Such related outbreaks in the U.S. in recent years have been wildly publicized and frightened the general population at large.

Funders and NGOs find new reporting standards favorable

According to the World Health Organization (WHO), some of the world’s largest funders of medical research and international non-governmental organizations (NGOs) recently agreed on new standards for clinical trials outcomes. Funded all clinical trials, per these new standards, are required to be registered with all results publicly disclosed. By all indications, funders and NGOs who agreed to the new standards find the new requirements favorable.

To read the full articles for this issue of The CenterWatch Weekly, please click here for subscription information